Akeso (HKG:9926) granted 7,115,000 share options to 114 grantees under its share option scheme at an exercise price of HK$84.60 apiece, according to a Monday filing with the Hong Kong bourse.
Chairperson Xia Yu is entitled to 3 million share options, the filing said.
The biopharmaceutical company will also offer 3,420,000 restricted share units to 107 grantees, including Xia, who will be entitled to 2 million RSUs, and six other directors.
The closing price of the shares is HK$83.15 per share, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.